KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update

KORU Medical Systems, Inc. (NASDAQ:KRMD) was the recipient of a significant drop in short interest in February. As of February 27th, there was short interest totaling 718,095 shares, a drop of 17.5% from the February 12th total of 869,950 shares. Based on an average trading volume of 169,541 shares, the days-to-cover ratio is currently 4.2 days. Approximately 2.0% of the company’s stock are short sold. Approximately 2.0% of the company’s stock are short sold. Based on an average trading volume of 169,541 shares, the days-to-cover ratio is currently 4.2 days.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on KRMD shares. Canaccord Genuity Group reiterated a “buy” rating and issued a $6.00 price target on shares of KORU Medical Systems in a research note on Friday. Lake Street Capital lifted their target price on shares of KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a report on Monday, December 22nd. B. Riley Financial upped their target price on shares of KORU Medical Systems from $7.00 to $8.00 and gave the stock a “buy” rating in a research note on Friday. Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered shares of KORU Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Saturday. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $6.50.

KORU Medical Systems Price Performance

NASDAQ KRMD traded up $0.01 during trading hours on Monday, hitting $4.29. The company’s stock had a trading volume of 260,958 shares, compared to its average volume of 201,787. KORU Medical Systems has a 12 month low of $1.86 and a 12 month high of $6.61. The company’s 50 day simple moving average is $5.10 and its two-hundred day simple moving average is $4.80. The company has a market cap of $198.93 million, a P/E ratio of -71.50 and a beta of 0.47.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. KORU Medical Systems had a negative net margin of 6.41% and a negative return on equity of 15.90%. The business had revenue of $10.90 million for the quarter, compared to analysts’ expectations of $10.90 million. As a group, research analysts predict that KORU Medical Systems will post -0.13 earnings per share for the current fiscal year.

Institutional Investors Weigh In On KORU Medical Systems

A number of large investors have recently added to or reduced their stakes in KRMD. Simcoe Capital LLC purchased a new stake in KORU Medical Systems during the 4th quarter valued at $3,921,000. Geode Capital Management LLC boosted its stake in shares of KORU Medical Systems by 101.3% in the 2nd quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after buying an additional 501,875 shares during the last quarter. Acuitas Investments LLC grew its holdings in shares of KORU Medical Systems by 89.6% in the third quarter. Acuitas Investments LLC now owns 763,088 shares of the company’s stock worth $2,923,000 after acquiring an additional 360,594 shares during the period. First Light Asset Management LLC increased its position in KORU Medical Systems by 5.1% during the second quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock valued at $16,760,000 after acquiring an additional 226,700 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its position in KORU Medical Systems by 189.5% during the first quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after acquiring an additional 158,914 shares during the last quarter. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.